About KDL

KDL is trusted by physicians, patients and other laboratories alike for the most accurate and reliable pathology services, with sub-specialty expertise in inflammatory and neoplastic skin disorders, ocular disease and surgical pathology. Prompt, courteous service reflects our commitment to quality patient care. KDL  consistently scores highest in client satisfaction for diagnostics and client support.

KDL Pathology is physician owed and was established as Knoxville Dermatopathology Laboratory in 1997 by Dr. Paul Googe as the only laboratory in East Tennessee, and one of few in the U.S., that specializes in skin and eye disease. In addition, KDL premier surgical pathology services include expertise in areas such as breast biopsies/cores, gynecology biopsies, blood smears, fine needle aspiration and podiatry.

Skilled Professional Service…Fast & Accurate Results
All biopsies sent to KDL are processed in our state-of-the-art laboratory, overseen by our quality assurance program. Most biopsy results are reported within 24 hours of specimen receipt by our full-time board-certified pathologists who are always available by phone to discuss your case. Our pathologists believe partnering with physicians and hospitals for a community based approach to diagnostics and treatment puts the focus back on the patient.


  • Dermatopathology
  • Ocular pathology
  • Surgical pathology
  • Veterinary pathology

Recognized Expertise
All KDL pathologists are board-certified by the American Board of Pathology (ABP). In addition, KDL dermatopathologists are board-certified by the American Board of Dermatology and ABP, and KDL ocular pathologists are certified by the American Board of Ophthalmology and ABP.

The pathologists at KDL are considered key opinion leaders in their field of expertise and are actively involved in teaching, research and publication in peer-review journals.

News and Events

Cancer survivors may be at higher risk of developing Melanoma. Read report

FDA approves Erivedge, the first drug to treat advanced basal cell carcinoma. Story

Diagnostic Update

KDL now providing FDA-approved BRAF testing for all metastatic melanomas. More

Contact Us

facebook icon

Stay Connected

Receive the DermPath Update or hear the latest news from KDL Pathology.